Bone Targeted Theranostics with 18F-NaF/ 223Ra Cl2 in Prostate Cancer - Hossein Jadvar
March 10, 2020
Hossein Jadvar presents on the use of sodium fluoride and radium-223 as a theranostic pair in the treatment of patients with metastatic prostate cancer. 18F-sodium fluoride has experienced a remarkable recent renaissance in the management of neuroendocrine tumors and prostate cancer. Dr. Jadvar presents this information during the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
Biographies:
Hossein Jadvar, MD, Ph.D., MPH, MBA, Associate Professor of Radiology, Associate Professor of Biomedical Engineering, The University of Southern California, Previous President of the Society of Nuclear Medicine.
Biographies:
Hossein Jadvar, MD, Ph.D., MPH, MBA, Associate Professor of Radiology, Associate Professor of Biomedical Engineering, The University of Southern California, Previous President of the Society of Nuclear Medicine.